Kenvue Inc.
NYSE KVUE
Kenvue Inc. Market Capitalization on January 14, 2025: USD 40.32 B
-
Kenvue Inc. 52-week high Market Capitalization is USD 46.51 B on December 02, 2024, which is 15.36% above the current Market Capitalization.
-
Kenvue Inc. 52-week low Market Capitalization is USD 33.94 B on July 10, 2024, which is -15.83% below the current Market Capitalization.
-
Kenvue Inc. average Market Capitalization for the last 52 weeks is USD 39.80 B.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Mr. Thibaut Mongon |
| IPO Date | May 4, 2023 |
| Location | United States |
| Headquarters | 199 Grandview Road |
| Employees | 22,000 |
| Sector | Consumer Staples |
| Industries | |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email